Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.76 |
| ▸ | USP2 | O75604 | 3/20 | 0.76 |
| ▸ | POLB | P06746 | 2/20 | 0.76 |
| ▸ | ATM | Q13315 | 1/20 | 0.76 |
| ▸ | PLEC | Q15149 | 1/20 | 0.76 |
| ▸ | ALPL | P05186 | 1/20 | 0.60 |
| ▸ | ALPI | P09923 | 1/20 | 0.60 |
| ▸ | ALPG | P10696 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 5/20 | 0.59 |
| ▸ | CA12 | O43570 | 4/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | TNKS | O95271 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.48 |
| ▸ | QPCT | Q16769 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14044262 | 0.86 | USP2 (0.77) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL940682 | 0.86 | MEN1 (1.00) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL14210376 | 0.85 | MEN1 (0.71) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL10082267 | 0.84 | MEN1 (0.72) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL13320830 | 0.84 | USP2 (0.76) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL29974216 | 0.84 | USP2 (0.76) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL10030600 | 0.83 | USP2 (0.64) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909281 | 0.82 | USP2 (0.62) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL9910747 | 0.81 | MEN1 (0.72) | MEN1KMT2AUSP2POLBATM | |
| SCHEMBL12909301 | 0.81 | USP2 (0.68) | MEN1KMT2AUSP2POLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170082642-A1 | FLUORESCENT CELL MARKERS | KODE BIOTECH LTD (NZ) | 2017-03-23 | — | — | US | disclosed |
| US-7439035-B1 | Method of identifying or characterizing a compound that modulates ribonuclease H activity | MCGILL UNIVERSITY (CA) | 2008-10-21 | — | — | US | disclosed |
| US-7186520-B1 | Substrate for assaying ribonuclease H activity | MCGILL UNIVERSITY (CA) | 2007-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170082642-A1 | FLUORESCENT CELL MARKERS | PTDSS2, SPTLC2, CD69 | MEN1 1577/4885KMT2A 3441/4885USP2 1329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.